<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04058899</url>
  </required_header>
  <id_info>
    <org_study_id>Use of dexmedetomidine</org_study_id>
    <nct_id>NCT04058899</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics</brief_title>
  <official_title>Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to compare the effect of IV infusion 0.5 µg/kg
      dexmedetomidine and IV 0.1 mg/kg nalbuphine in preschool children for prevention of emergence
      agitation after adenotonsillectomy under sevoflurane anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Consent will be obtained from legal guardian of children,patients will be randomized
      according to computer randomization to one of two groups, dexmedetomidine group (DEX)group
      who will receive 0.5 µg/kg dexmedetomidine diluted in 50 ml of normal saline 0.9% to be given
      by IV infusion over 10 minutes after induction of anesthesia then 5ml of 0.9% normal saline
      IV ,nalbuphine group (NAL)group will receive IV infusion of 50 ml of 0,9%normal saline by IV
      infusion over 10 minutes then 0.1mg/kg nalbuphine diluted in 5ml of 0.9%normal saline IV
      after induction of anesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 5, 2019</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be divided into 2 groups ,dexmedetomidine group (DEX)group who will receive 0.5 µg/kg dexmedetomidine diluted in 50 ml of normal saline 0.9% to be given by IV infusion over 10 minutes after induction of anesthesia then 5ml of 0.9% normal saline IV ,nalbuphine group (NAL)group will receive IV infusion of 50 ml of 0,9%normal saline by IV infusion over 10 minutes then 0.1mg/kg nalbuphine diluted in 5ml of 0.9%normal saline IV after induction of anesthesia.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative agitation prevention in pediatrics after adenotonsillectomy under sevoflurane anesthesia</measure>
    <time_frame>stay in postoperative care unit till discharge of patient to ward.Time frame is up to 24 weeks</time_frame>
    <description>during stay in postoperative care unit using pediatric anesthesia emergence delirium score (PAED) as score equal or more than 16/20 is considered presence of agitation. during stay in postanesthesia care unit,score will be documented every 10 minutes by recovery staff.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>sedation in early postopertive time during child stay in postanesthesia care unit</measure>
    <time_frame>stay in postoperative care unit till discharge of patient to ward.Time frame is up to 24 weeks</time_frame>
    <description>stay in postoperative care unit using Ramsay sedation score evey 10 minutes till discharge to ward,assessed by recovery staff..Presence of score 4/6 or more means that child is sedated,and needs more time in recovery,..</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Emergence Delirium</condition>
  <arm_group>
    <arm_group_label>, Dexmedetomidine group(DEX group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>dexmedetomidine group (DEX)group who will receive 0.5 µg/kg dexmedetomidine diluted in 50 ml of normal saline 0.9% to be given by IV infusion over 10 minutes after induction of anesthesa then 5ml of 0.9% normal saline IV ,</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nalbuphine group(NAL group)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>nalbuphine group (NAL)group will receive IV infusion of 50 ml of 0,9%normal saline by IV infusion over 10 minutes then 0.1mg/kg nalbuphine diluted in 5ml of 0.9%normal saline IV after induction of anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>sedative and might be analgesic drug</description>
    <arm_group_label>, Dexmedetomidine group(DEX group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nalbuphine</intervention_name>
    <description>agonist antagonist narcotic</description>
    <arm_group_label>Nalbuphine group(NAL group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>infusion pump</intervention_name>
    <description>infusion pump for titration of fluid containing drug infusion</description>
    <arm_group_label>, Dexmedetomidine group(DEX group)</arm_group_label>
    <arm_group_label>Nalbuphine group(NAL group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children of (American Society of Anesthesiologist)ASA physical status grade I or II.

          -  Aged 2-5 years

          -  Undergoing elective adenotonsillectomy.

        Exclusion Criteria:

          -  History of hypersensitivity to the studied drug.

          -  Refusal of the legal guardian to participate in the study.

          -  Severely agitated child at induction of anesthesia

          -  Occurrence of postoperative bleeding at(Post Anesthesia Care Unit) PACU
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11566</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 29, 2019</study_first_submitted>
  <study_first_submitted_qc>August 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2019</study_first_posted>
  <last_update_submitted>August 16, 2019</last_update_submitted>
  <last_update_submitted_qc>August 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ashraf Elsayed Elagamy</investigator_full_name>
    <investigator_title>Assisstant proffesor</investigator_title>
  </responsible_party>
  <keyword>dexmedetomidine</keyword>
  <keyword>emergence agitation</keyword>
  <keyword>adenotonsillectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Nalbuphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

